Article ; Online: Is there a role for immune-enhancing therapies for acutely ill patients with coronavirus disease 2019?
Current opinion in critical care
2021 Volume 27, Issue 5, Page(s) 480–486
Abstract: Purpose of review: Although the so-called cytokine storm has been early described and related to a dramatic evolution in severe COVID-19 patients, it soon became clear that those patients display clinical and biological evidence of an immunosuppressive ... ...
Abstract | Purpose of review: Although the so-called cytokine storm has been early described and related to a dramatic evolution in severe COVID-19 patients, it soon became clear that those patients display clinical and biological evidence of an immunosuppressive state characterized, among other, by a profound lymphopenia. The negative role of this immune suppression on the outcome raises the question on immune therapies that might improve patient's condition. Recent findings: Important positive effects of active immune therapies, such as IL-7 or thymosin-α are already described and warrant confirmation in larger prospective trials. For other therapies, such as interferons, firm conclusions for critically ill COVID-19 patients are lacking as those patients were often excluded from the published trials. Treatment with immunoglobulins or convalescent plasma is a passive strategy to provide specific immunity. Unfortunately, results from large RCTs do not support their use presently. Summary: In this article, we provide a review on active and passive immune boosting strategies that might help treating the most severe COVID-19 patients. We mainly focus on active strategies that include IL-7, thymosin-α, interferons, and vitamin D. Although some positive effects are described, they certainly warrant confirmation in large randomized controlled trials. |
---|---|
MeSH term(s) | COVID-19/therapy ; Coronavirus Infections ; Humans ; Immunization, Passive ; Prospective Studies ; SARS-CoV-2 ; COVID-19 Serotherapy |
Language | English |
Publishing date | 2021-07-31 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 1235629-3 |
ISSN | 1531-7072 ; 1070-5295 |
ISSN (online) | 1531-7072 |
ISSN | 1070-5295 |
DOI | 10.1097/MCC.0000000000000862 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4999: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.